RESUMO
PURPOSE: The Universal Newborn Hearing Screening (UNHS) looks for early diagnosis and rehabilitation of newborns at risk or not of hearing impairment. The purpose is analyze the flow of Universal Newborn Hearing Screening in the family health care strategy unit through the tracking and monitoring of children. METHODS: This is a quantitative and retrospective study. The trace begins with the third copy of the Live Newborn Declaration, filled in at the maternity ward. An interview with parents and guardians was made by a community agent at the Health Unit or at the home of the newborn. Monitoring was conducted by live birth declaration and the information collected by the interviewer from maternal and child health booklet and the follow-up at high complexity services. RESULTS: The sample was made up of 50 neonates. 52% were between 30 and 89 days and 54% were male. 12% of newborns presented a risk factor for hearing loss and the neonatal screening was performed in 86% of cases. Hearing health measures show integrality in hearing impairment care at the basic health unit to high complexity hospital. CONCLUSION: The flow of care for newborn hearing screening is in agreement with the child health care guidelines in Curitiba, however, it is not yet universal. In conclusion, the participation of the family health strategy unit in the tracking and monitoring of children submitted to the Universal newborn hearing screening program is feasible and recommended.
Assuntos
Perda Auditiva/diagnóstico , Triagem Neonatal/métodos , Brasil , Atenção à Saúde , Saúde da Família , Feminino , Seguimentos , Testes Auditivos/métodos , Humanos , Lactente , Recém-Nascido , Masculino , Programas Nacionais de Saúde , Valores de Referência , Estudos Retrospectivos , Medição de Risco , Fatores de RiscoRESUMO
RESUMO Objetivo A Triagem Auditiva Neonatal Universal (TANU) visa ao diagnóstico precoce e à reabilitação de neonatos em situação de risco ou não para deficiência auditiva. O objetivo principal foi analisar o fluxo de Triagem Auditiva Neonatal Universal em Unidade de Estratégia de Saúde da Família por meio do rastreamento e monitoramento das crianças. Método É um estudo retrospectivo, quantitativo. O rastreamento foi realizado a partir da terceira via da Declaração de Nascido Vivo preenchida na maternidade. O monitoramento foi realizado pela ficha de acompanhamento do recém-nascido preenchida pelo agente comunitário e uma entrevista com os pais ou responsáveis, na unidade da Secretaria Municipal de Saúde, ou por visita domiciliar. Também foram coletadas informações na caderneta de saúde da criança e acompanhamento em serviços de alta complexidade. Resultados A casuística foi constituída por 50 neonatos, sendo que 52% deles estavam entre 30 e 89 dias de vida e 54% eram do gênero masculino. Apresentaram fator de risco para deficiência auditiva, 12% dos neonatos e 86% realizaram a triagem neonatal. As ações em Saúde Auditiva mostram que está havendo integralidade de atendimento na etapa hospitalar e ambulatorial, na unidade básica de saúde analisada e em serviços de alta complexidade. Conclusão O fluxo de atendimento em Triagem Auditiva Neonatal Universal converge para a Diretriz de Atenção à Saúde da Criança Curitibana, mas ainda não é universal. Concluindo-se assim, que a participação da Unidade de Estratégia de Saúde da Família, no rastreamento e monitoramento das crianças submetidas ao programa de Triagem Auditiva Neonatal Universal no município, é viável e recomendada.
ABSTRACT Purpose The Universal Newborn Hearing Screening (UNHS) looks for early diagnosis and rehabilitation of newborns at risk or not of hearing impairment. The purpose is analyze the flow of Universal Newborn Hearing Screening in the family health care strategy unit through the tracking and monitoring of children. Methods This is a quantitative and retrospective study. The trace begins with the third copy of the Live Newborn Declaration, filled in at the maternity ward. An interview with parents and guardians was made by a community agent at the Health Unit or at the home of the newborn. Monitoring was conducted by live birth declaration and the information collected by the interviewer from maternal and child health booklet and the follow-up at high complexity services. Results The sample was made up of 50 neonates. 52% were between 30 and 89 days and 54% were male. 12% of newborns presented a risk factor for hearing loss and the neonatal screening was performed in 86% of cases. Hearing health measures show integrality in hearing impairment care at the basic health unit to high complexity hospital. Conclusion The flow of care for newborn hearing screening is in agreement with the child health care guidelines in Curitiba, however, it is not yet universal. In conclusion, the participation of the family health strategy unit in the tracking and monitoring of children submitted to the Universal newborn hearing screening program is feasible and recommended.
Assuntos
Humanos , Masculino , Feminino , Recém-Nascido , Lactente , Triagem Neonatal/métodos , Perda Auditiva/diagnóstico , Valores de Referência , Brasil , Saúde da Família , Estudos Retrospectivos , Fatores de Risco , Seguimentos , Medição de Risco , Atenção à Saúde , Testes Auditivos/métodos , Programas Nacionais de SaúdeRESUMO
Background: Treatment failure in patients receiving antiretroviral therapy against human immunodeficiency virus (HIV) is always a concern. Objective: To examine the correlates associated with treatment failure in patients living in the Colombian Caribbean city of Barranquilla, an aspect that was poorly studied in this region. Methods: Treatment failure (TF) was evaluated in a cross-sectional study from virological, immunological and clinical standpoints. Results: It was established that 29.5% of patients under highly active antiretroviral therapy (ART) could be considered in TF. Among those, virological failure was most frequent (20.9%), followed by immunological- (14.0%) and clinical failure (4.7%). In patients showing lack of adherence to the treatment, the likelihood of suffering from treatment- and virogical-failure were respectively increased by 6.67-fold and 12.19-fold, compared with patients showing good adherence. Although there was no statistically significant association, TF tended to be more frequent in young adults, in patients with low income and, low level of education. When ART regimens were compared, there was no apparent difference in TF between regimens based on non-nucleoside reverse transcriptase inhibitors and those based on protease inhibitors. This is very important in the context of recent ART strategies, such as early-initiated ART, aimed at achieving long-term infection control. Conclusions: Is confirmed the importance of treatment adherence to avoid TF and further highlights the importance of educating HIV-infected patients in all parts of the world, especially those individuals with a lower socio-economic status.
Antecedentes: El fracaso terapéutico (FT) en pacientes que están recibiendo terapia antirretroviral contra el Virus de la Inmunodeficiencia Humana (VIH) ha sido siempre preocupante. Objetivo: Examinar las variables asociadas con el FT, un problema que ha sido pobremente estudiado en la región, en pacientes que habitan en Barranquilla, ciudad del Caribe colombiano. Métodos: El FT fue evaluado en un estudio transversal desde los puntos de vista virológico, inmunológico y clínico. Resultados: Se determinó que el 29.5% de los pacientes bajo terapia antirretroviral (TAR) de gran actividad podría considerase en FT. El fracaso virológico fue el más frecuente (20.9%), seguido por el inmunológico (14.0%) y el clínico (4.7%). En pacientes que mostraron falta de adherencia al tratamiento, las posibilidades de presentar un FT y virológico fue mayor, 6.67 y 12.19 veces, respectivamente, comparados con pacientes que mostraron buena adherencia. Aun cuando no hubo una asociación estadística significativa, el FT tendió a ser más frecuente en adultos jóvenes, en pacientes con bajos ingresos y bajo nivel de educación. Cuando se compararon diferentes regímenes de TAR no hubo una diferencia aparente entre el FT en los regímenes basados en inhibidores no nucleósidos de la transcriptasa inversa y en aquellos basados en inhibidores de la proteasa. Esto es muy importante en el contexto de recientes estrategias de TAR, como es el caso de las iniciadas en forma temprana con el fin de lograr el control de la infección a largo plazo. Conclusiones: Se confirma la importancia de la adherencia al tratamiento para evitar el FT y la importancia de educar a los pacientes infectados con el VIH, especialmente aquellos individuos con un nivel socioeconómico bajo.
Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/tratamento farmacológico , Adesão à Medicação , Educação de Pacientes como Assunto/métodos , Fármacos Anti-HIV/administração & dosagem , Colômbia , Estudos Transversais , Fatores Socioeconômicos , Falha de TratamentoRESUMO
BACKGROUND: Treatment failure (TF) in patients receiving antiretroviral therapy against human immunodeficiency virus (HIV) is always a concern. OBJECTIVE: To examine the correlates associated with TF in patients living in the Colombian Caribbean city of Barranquilla, an aspect that was poorly studied in this region. METHODS: Treatment failure was evaluated in a cross-sectional study from virological, immunological and clinical standpoints. RESULTS: It was established that 29.5% of patients under highly active antiretroviral therapy (ART) could be considered in TF. Among those, virological failure was most frequent (20.9%), followed by immunological- (14.0%) and clinical failure (4.7%). In patients showing lack of adherence to the treatment, the likelihood of suffering from TF and virogical failure were respectively increased by 6.67-fold and 12.19-fold, compared with patients showing good adherence. Although there was no statistically significant association, TF tended to be more frequent in young adults, in patients with low income and, low level of education. When ART regimens were compared, there was no apparent difference in TF between regimens based on non-nucleoside reverse transcriptase inhibitors and those based on protease inhibitors. This is very important in the context of recent ART strategies, such as early-initiated ART, aimed at achieving long-term infection control. CONCLUSIONS: Is confirmed the importance of treatment adherence to avoid TF and further highlights the importance of educating HIV-infected patients in all parts of the world, especially those individuals with a lower socio-economic status.
OBJETIVOS: El fracaso terapéutico (FT) en pacientes que están recibiendo terapia antirretroviral contra el Virus de la Inmunodeficiencia Humana (VIH) ha sido siempre preocupante. OBJETIVO: Examinar las variables asociadas con el fracaso terapéutico, un problema que ha sido pobremente estudiado en la región, en pacientes que habitan en Barranquilla, ciudad del Caribe colombiano. MÉTODOS: El fracaso terapéutico fue evaluado en un estudio transversal desde los puntos de vista virológico, inmunológico y clínico. RESULTADOS: Se determinó que el 29.5% de los pacientes bajo terapia antirretroviral (TAR) de gran actividad podría considerase en fracaso terapéutico. El fracaso virológico fue el más frecuente (20.9%), seguido por el inmunológico (14.0%) y el clínico (4.7%). En pacientes que mostraron falta de adherencia al tratamiento, las posibilidades de presentar un fracaso terapéutico y virológico fue mayor, 6.67 y 12.19 veces, respectivamente, comparados con pacientes que mostraron buena adherencia. Aun cuando no hubo una asociación estadística significativa, el fracaso terapéutico tendió a ser más frecuente en adultos jóvenes, en pacientes con bajos ingresos y bajo nivel de educación. Cuando se compararon diferentes regímenes de TAR no hubo una diferencia aparente entre el fracaso terapéutico en los regímenes basados en inhibidores no nucleósidos de la transcriptasa inversa y en aquellos basados en inhibidores de la proteasa. Esto es muy importante en el contexto de recientes estrategias de TAR, como es el caso de las iniciadas en forma temprana con el fin de lograr el control de la infección a largo plazo. CONCLUSIONES: Se confirma la importancia de la adherencia al tratamiento para evitar el fracaso terapéutico y la importancia de educar a los pacientes infectados con el VIH, especialmente aquellos individuos con un nivel socioeconómico bajo.
Assuntos
Fármacos Anti-HIV/uso terapêutico , Infecções por HIV/tratamento farmacológico , Adesão à Medicação , Educação de Pacientes como Assunto/métodos , Adulto , Fármacos Anti-HIV/administração & dosagem , Colômbia , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores Socioeconômicos , Falha de Tratamento , Adulto JovemRESUMO
En este artículo se reporta un caso de un adulto joven de 27 años de edad, quien presentó una masa blanda de crecimiento progresivo posterior a un trauma. El diagnóstico de seudoaneurisma de la arteria temporal superficial se generó utilizando ultrasonido Doppler luego de un diagnóstico inconcluso, debido a la ausencia de contraste utilizando tomografía computarizada simple. En este caso, se demuestra la utilidad de una técnica relativamente económica y accesible como método inicial en el protocolo de manejo.